FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+27.78%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$104M
AUM Growth
+$104M
(-12%)
Cap. Flow
-$11M
Cap. Flow
% of AUM
-10.53%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
5
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
Karyopharm Therapeutics
KPTI
|
$10.5M |
| 2 |
Talphera
TLPH
|
$174K |
| 3 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$171K |
| 4 |
Xencor
XNCR
|
$92.6K |
| 5 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
$63.9K |
Sector Composition
| 1 | Healthcare | 69.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Karyopharm Therapeutics
KPTI
$61.7M
| $37.6M | 36.04% | 1,077,124 -300,286 | -22% | -$10.5M |
|
|
AMBI
2
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $32M | 30.67% | 2,079,569 | – | – |
|
|
BDSI
3
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $11.8M | 11.29% | 690,000 -10,000 | -1% | -$171K |
|
|
4
Xencor
XNCR
$580M
| $7.52M | 7.2% | 807,356 -9,944 | -1% | -$92.6K |
|
|
OREX
5
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $5.26M | 5.04% | 1,235,000 -15,000 | -1% | -$63.9K |
|
|
6
Talphera
TLPH
$11.1M
| $4.48M | 4.29% | 816,251 -31,732 | -4% | -$174K |
|
|
RXDX
7
DELISTED
Ignyta, Inc.
RXDX
| $4.03M | 3.86% | 500,000 | – | – |
|
|
XLRN
8
DELISTED
Acceleron Pharma Inc.
XLRN
| $1.69M | 1.61% | 55,767 | – | – |
|